fbpx

Presentation of “A RANDOMIZED DOUBLED BLINDED TRIAL OF TREATMENT WITH DIAMINO-OXIDASE (DAO) IN PATIENTS WITH MIGRAINE AND DEFICIT OF ENZYME’S ACTIVITY. ” in the XXI World Congress of Neurology in Vienna

PrevNext
DR Healthcare makes available to Pharmacies, Companies and Public and Private Institutions its Reusable Face MaskUNE-0065/2020, AFNOR and DGA